REQUEST A DEMO
Total
USD $0.00
Search more companies

Lotos Pharma SIA (Latvia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Lotos Pharma SIA Profile Updated: December 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Lotos Pharma SIA is an enterprise located in Latvia, with the main office in Marupe. The company operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on February 19, 2013. 31 (2023) employees currently work for Lotos Pharma SIA. From the latest financial highlights, Lotos Pharma SIA reported a net sales revenue increase of 7.18% in 2024. Its’ total assets recorded a growth of 25.87%. Lotos Pharma SIA’s net profit margin increased by 0.09% in 2024.

Headquarters
Plienciema iela 16
Marupe; Marupes municipality; Postal Code: 2167

Contact Details: Purchase the Lotos Pharma SIA report to view the information.

Basic Information
Total Employees:
Purchase the Lotos Pharma SIA report to view the information.
Registered Capital:
Purchase the Lotos Pharma SIA report to view the information.
Financial Auditors:
Purchase the Lotos Pharma SIA report to view the information.
Incorporation Date:
February 19, 2013
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Lotos Pharma SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
7.18%
Total operating revenue
6.45%
Operating profit (EBIT)
10.28%
EBITDA
10.28%
Net Profit (Loss) for the Period
7.78%
Total Assets
25.87%
Total Equity
34.09%
Operating Profit Margin (ROS)
0.52%
Net Profit Margin
0.09%
Return on Equity (ROE)
-6.76%
Quick Ratio
0.6%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?